At the completion of this article, the reader should be able to improve their knowledge of emerging myopia control interventions,...
Read moreDetailsAt the completion of this article, the reader should be able to discuss RLRL with their myopia patients, including: Understand...
Read moreDetailsRepeated low-level red-light (RLRL) device manufacturer Eyerising International says the reclassification of the emerging myopia management intervention in China is...
Read moreDetailsSydney ophthalmologist DR NISHA SACHDEV dissects low light level therapy, a new tool generating what she describes as remarkable, non-invasive...
Read moreDetailsAustralian medical device company Eyerising International says its device has been “misrepresented” in a recent study over the safety...
Read moreDetailsMore eye clinics are elevating their dry eye service by investing in an intense pulsed light system. An Australian optometrist...
Read moreDetailsEyerising International has addressed questions over the safety of its repeated-low level red-Light (RLRL) treatment for myopia management, following two...
Read moreDetailsOver two evening events in Sydney and Melbourne, medical device company InMode will host Canadian optometrist Dr Bruce Dornn to...
Read moreDetailsA recent paper investigating transcutaneous radiofrequency (RF)-assisted meibomian gland expression using the InMode Envision platform and Forma-I handpiece in dry...
Read moreDetailsInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited